← Back to headlines
Merck's Keytruda Shows Survival Benefit in Ovarian Cancer
Merck's cancer drug Keytruda has demonstrated an overall survival benefit in patients with ovarian cancer, according to new findings.
27 Feb, 16:38 — 27 Feb, 16:38
Sources
Showing 1 of 1 sources
Related Stories
Hayden Panettiere's Health Struggles Before Her Death Revealed
1h ago
Airline Pilots Face Highest Cancer Risk from Radiation Exposure
1h ago
Study Reveals Elderly More Vulnerable to Extreme Heat Than Previously Thought
4h ago
Nollywood Actor Ogogo Hassan's Daughters Seek Help for Father's Stage 4 Cancer
8h ago